SYNOVIAL SARCOMAS
Clinical trials for SYNOVIAL SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMAS trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy for childhood cancers enters human trials
Disease control Recruiting nowThis study tests a combination of two drugs—Lutathera (a targeted radiation therapy) and olaparib (a PARP inhibitor)—in children and teens aged 3 to 18 with solid tumors that have come back or not responded to standard treatment. The goal is to find the safest dose and see if the…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
Proton beams take aim at inoperable sarcomas in new trial
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control soft tissue sarcomas that cannot be surgically removed. About 40 adults in Norway will receive radiation over 4 weeks, with the highest dose focused on the tumor center. Researchers will also look at bl…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for tough cancers: first human trial of AOH1996 begins
Disease control Recruiting nowThis early-stage study is testing a new drug, AOH1996, in adults with solid tumors (like lung, ovarian, or pancreatic cancer) that have stopped responding to standard treatments. The main goals are to find a safe dose and understand side effects. The drug works by blocking certai…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
New 3-Week radiation plan aims to cut side effects for sarcoma patients
Disease control Recruiting nowThis study tests whether a personalized, 3-week course of proton or x-ray radiation before surgery can reduce long-term side effects for adults with soft tissue sarcoma. About 110 participants will have two radiation plans made, and a national team will choose the best one for ea…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated May 08, 2026 12:04 UTC
-
New cell therapy shows promise for rare sarcoma
Disease control Recruiting nowThis study tests a new treatment called TBI-1301 (mip-cel) for people with a rare type of cancer called synovial sarcoma. The treatment uses the patient's own immune cells, modified to attack cancer cells. The goal is to see if it can shrink tumors safely. The study is for adults…
Matched conditions: SYNOVIAL SARCOMAS
Phase: PHASE3 • Sponsor: Takara Bio Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC